CAS 223673-61-8

Mirabegron

Description:

Mirabegron is a pharmaceutical compound primarily used as a medication for the treatment of overactive bladder. It functions as a selective beta-3 adrenergic agonist, which means it stimulates beta-3 adrenergic receptors in the bladder, leading to relaxation of the detrusor muscle and increased bladder capacity. This mechanism helps alleviate symptoms such as urgency and frequency of urination. Mirabegron is characterized by its moderate lipophilicity, which influences its absorption and distribution in the body. The compound has a molecular formula that reflects its complex structure, including various functional groups that contribute to its pharmacological activity. It is typically administered orally and has a relatively long half-life, allowing for once-daily dosing. Common side effects may include hypertension, urinary tract infections, and headache. Overall, Mirabegron represents a significant advancement in the management of urinary conditions, providing an alternative to anticholinergic medications.

Formula: C₂₁H₂₄N₄O₂S

InChI: InChI=1/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)

InChI key: InChIKey=PBAPPPCECJKMCM-IBGZPJMESA-N

SMILES: N(C(CC1=CSC(N)=N1)=O)C2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2

Synonyms:

• (R)-Mirabegron
• 2-(2-Amino-1,3-thiazol-4-yl)-N-[4-[2-[((2R)-2-hydroxy-2-phenylethyl)amino]ethyl]phenyl]acetamide
• 2-(2-amino-1,3-thiazol-4-yl)-N-(4-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl}phenyl)acetamide
• 2-Amino-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-4-thiazoleacetamide
• 4-Thiazoleacetamide, 2-amino-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-
• Betanis
• Betmiga
• Mira veron
• Myrbetriq
• N-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)-2-(2-aminothiazol-4-yl)acetamide
• Ym 178
• Mirabegron
• Merariveron impurity B
• Mirabegron(YM 178)
• (R)-2-(2-aminothiazol-4-yl)-N-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)acetamide
• hot selling Mirabegron
• Mirabello
• Mirabegron USP/EP/BP
• Mirabegron Intermediates
• 2-(2-Amino-1,3-thiazol-4-yl)-N-[4-(2-{[(2R)-2-hydroxy2-phenylethyl]amino}ethyl)phenyl]acetamide
• Mirabelon
• CS-732
• (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl}acetanilide
• MIRABEQRON
• (2R)-2-(2-AMinothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)aMino]ethyl]acetic Acid Anilide
• Mirabegron, >=99%
• 2-AMino-N-[4-[2-[[(2R)-2-hydroxy-2-phenyl-ethyl]aMino]-ethyl]phenyl]-4-thiazoleacetaMide

Mirabegron

CAS: 223673-61-8

Mirabegron

Formula: C₂₁H₂₄N₄O₂S

Purity: 99.9%

Color and Shape: White

Molecular weight: 396.162

Ref: 47-1313

MIRABEGRON CRS

CAS: 223673-61-8

MIRABEGRON CRS

Ref: 41-Y0002371

Mirabegron

CAS: 223673-61-8

Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure

Formula: C₂₁H₂₄N₄O₂S

Color and Shape: White Off-White Brownish Yellow Crystalline Powder

Molecular weight: 396.162

Ref: 45-1444106

Mirabegron

CAS: 223673-61-8

Mirabegron (YM178) is a beta-3 adrenergic agonist that is used for treatment of overactive bladder syndrome.

Formula: C₂₁H₂₄N₄O₂S

Purity: 99.64%

Color and Shape: Light Yellow To Yellow Solid

Molecular weight: 396.51

Ref: TM-T1671

2-(2-amino-1,3-thiazol-4-yl)-N-[4-(2-{[(2R)-2-hydroxy-2-phenylethyl]amino}ethyl)phenyl]acetamide

CAS: 223673-61-8

Formula: C₂₁H₂₄N₄O₂S

Purity: 97%

Color and Shape: Solid

Molecular weight: 396.5059

Ref: IN-DA0037SU

Mirabegron

CAS: 223673-61-8

Mirabegron

Purity: ≥98%

Molecular weight: 396.51g/mol

Ref: 54-BUP12771

Mirabegron

CAS: 223673-61-8

Mirabegron

Purity: 98%

Molecular weight: 396.506g/mol

Ref: 54-OR1027819

Mirabegron

CAS: 223673-61-8

Formula: C₂₁H₂₄N₄O₂S

Color and Shape: Pale Yellow Solid

Molecular weight: 396.51

Ref: 4Z-M-861

Mirabegron

CAS: 223673-61-8

Color and Shape: Neat

Ref: 86-MM3776.00

Mirabegron

Controlled Product

CAS: 223673-61-8

Formula: C₂₁H₂₄N₄O₂S

Color and Shape: White

Molecular weight: 396.51

Ref: TR-M364900

Mirabegron

CAS: 223673-61-8

Mirabegron is a drug that is used for the treatment of urinary incontinence and overactive bladder. It is a selective beta 3 adrenergic receptor agonist that has been shown to increase detrusor muscle contractility, thereby improving the storage capacity of the bladder. Mirabegron also decreases post-voiding residual volume and increases total voided volume. Mirabegron acts by binding to its receptor in adipose tissue, which leads to increased lipolysis and reduced appetite. The effect on lipolysis may be due to mirabegron's ability to inhibit DPP-IV activity.

Formula: C₂₁H₂₄N₄O₂S

Purity: Min. 95 Area-%

Color and Shape: White Off-White Powder

Molecular weight: 396.51 g/mol

Ref: 3D-FM26011